Business, Policy & Funding
Breaking news on precision medicine business, policy & funding.
The data company has ambitions to accelerate precision drug discovery and development by selling its customer data that comprises patients' complete healthcare experiences.
Kazia to Raise $2M in Registered Direct Offering
The firm, which is developing the PI3K pathway inhibitor paxalisib in brain cancer, will use the proceeds to fund general corporate expenses.
Neurogene Doses First Two Rett Syndrome Patients in Gene Therapy Trial
Participants in the first-in-human trial will receive the firm's NGN-401 gene therapy, which is designed to deliver a working copy of the MECP2 gene.
In Brief This Week: Sernova, Akeso, RoslinCT, GeNeuro, Effector Therapeutics, ARUP Laboratories
News items for the week of Nov. 27, 2023.
Gilead Lays off 7 Percent of Cell Therapy Staff to 'Optimize Operational Efficiency'
A spokesperson for the firm said Gilead is also adding 90 new employees to its cell therapy business unit Kite Pharma, making a net 5 percent total reduction.
Nov 30, 2023